Literature DB >> 18175037

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.

T Nakagomi1, L E Cuevas, R G Gurgel, S H Elrokhsi, Y A Belkhir, M Abugalia, W Dove, F M U Montenegro, J B Correia, O Nakagomi, N A Cunliffe, C A Hart.   

Abstract

The introduction of a G1P[8] rotavirus vaccine in Recife, Brazil, caused a decrease in rotavirus detection from 27% (March-May, 2006) to 5.0% (March-May, 2007), with all strains becoming G2, against which less protection had been predicted.

Mesh：

Substances：

Year:  2008        PMID： 18175037     DOI： 10.1007/s00705-007-0028-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  20 in total

Review 1.  Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.

Authors:  Keith Grimwood; Stephen B Lambert; Richard J Milne
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

2.  Effect of monovalent rotavirus vaccine on rotavirus disease burden and circulating rotavirus strains among children in Morocco.

Authors:  Mohammed Benhafid; Nezha Elomari; Meryem Azzouzi Idrissi; Ahmed Rguig; Jon R Gentsch; Umesh Parashar; Rajae Elaouad
Journal:  J Med Virol       Date:  2015-03-05       Impact factor: 2.327

3.  Increasing detection of rotavirus G2P[4] strains in Nizhny Novgorod, Russia, between 2016 and 2019.

Authors:  Olga V Morozova; Tatiana A Sashina; Natalia V Epifanova; Alexander Yu Kashnikov; Nadezhda A Novikova
Journal:  Arch Virol       Date:  2020-10-20       Impact factor: 2.574

4.  Phylogenetic comparison of the VP7, VP4, VP6, and NSP4 genes of rotaviruses isolated from children in Nizhny Novgorod, Russia, 2015-2016, with cogent genes of the Rotarix and RotaTeq vaccine strains.

Authors:  O V Morozova; T A Sashina; N V Epifanova; V V Zverev; A U Kashnikov; N A Novikova
Journal:  Virus Genes       Date:  2017-12-13       Impact factor: 2.332

5.  Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua.

Authors:  Filemón Bucardo; Christine M Rippinger; Lennart Svensson; John T Patton
Journal:  Infect Genet Evol       Date:  2012-04-02       Impact factor: 3.342

6.  Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.

Authors:  N Aliabadi; J E Tate; U D Parashar
Journal:  Clin Microbiol Infect       Date:  2016-04-26       Impact factor: 8.067

7.  Prevalence and molecular genotyping of group a rotaviruses in Iranian children.

Authors:  Mohammad Kargar; Amin Reza Akbarizadeh
Journal:  Indian J Virol       Date:  2012-04-27

Review 8.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

9.  Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines.

Authors:  Aruna Chandran; Sean Fitzwater; Anjie Zhen; Mathuram Santosham
Journal:  Biologics       Date:  2010-08-09

10.  Burden of Norovirus and Rotavirus in Children After Rotavirus Vaccine Introduction, Cochabamba, Bolivia.

Authors:  Casey L McAtee; Rachel Webman; Robert H Gilman; Carolina Mejia; Caryn Bern; Sonia Apaza; Susan Espetia; Mónica Pajuelo; Mayuko Saito; Roxanna Challappa; Richard Soria; Jose P Ribera; Daniel Lozano; Faustino Torrico
Journal:  Am J Trop Med Hyg       Date:  2015-11-23       Impact factor: 2.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.